Screener
Supernus Pharmaceuticals SUPN Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Supernus Pharmaceuticals’s reported figures.
The source filing: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001356576-26-000022
FAQ
- What is Supernus Pharmaceuticals's gross profit?
- Supernus Pharmaceuticals (SUPN) reported gross profit of $184.31M in Q1 2026.
- How has Supernus Pharmaceuticals's gross profit changed year-over-year?
- Supernus Pharmaceuticals's gross profit increased by 37.5% year-over-year, from $134.06M to $184.31M.
- What is the long-term trend for Supernus Pharmaceuticals's gross profit?
- Over 4 years (2021 to 2025), Supernus Pharmaceuticals's gross profit has grown at a 6.3% compound annual growth rate (CAGR), from $504.71M to $644.39M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Supernus Pharmaceuticals's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude